Biogen Inc. ($BIIB)
Filing Information
| Accession Number | 0000875045-26-000033 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 18, 2026 |
| Document Date | Feb 12, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
10,563
Total Value
$585.11
P&L
+327492.8% (+$1,916,176.88)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Head of Pharm Ops and Tech | Common Stock | โ | Feb 12, 2026 | Purchase | 3 | $195.03 | $585.11 | 19,611 | Direct | โ | View Details | |
Head of Pharm Ops and Tech | Restricted Stock Unit | Derivative | Feb 13, 2026 | Grant/Award | 10,560 | $0.00 | $0.00 | 10,560 | Direct | โ | View Details |